Advertisement

 

 

Latin-American guidelines for opioid use in chronic nononcologic pain.

Latin-American guidelines for opioid use in chronic nononcologic pain.
Author Information (click to view)

Lara-Solares A, Aguayo Zamora C, Amescua García C, Garcia JB, Berenguel Cook MD, Bonilla Sierra P, Campos Kraychete D, Flores Cantisani JA, Guerrero C, Guillén Núñez MD, Hernández Castro JJ, Hernández Ortíz A, Jreige Iskandar A, Lech O, Macías Guerra J, Ramírez Samayoa G, Rangel Morillo E, Rico Pazos MA, Sempértegui Gallegos M,


Lara-Solares A, Aguayo Zamora C, Amescua García C, Garcia JB, Berenguel Cook MD, Bonilla Sierra P, Campos Kraychete D, Flores Cantisani JA, Guerrero C, Guillén Núñez MD, Hernández Castro JJ, Hernández Ortíz A, Jreige Iskandar A, Lech O, Macías Guerra J, Ramírez Samayoa G, Rangel Morillo E, Rico Pazos MA, Sempértegui Gallegos M, (click to view)

Lara-Solares A, Aguayo Zamora C, Amescua García C, Garcia JB, Berenguel Cook MD, Bonilla Sierra P, Campos Kraychete D, Flores Cantisani JA, Guerrero C, Guillén Núñez MD, Hernández Castro JJ, Hernández Ortíz A, Jreige Iskandar A, Lech O, Macías Guerra J, Ramírez Samayoa G, Rangel Morillo E, Rico Pazos MA, Sempértegui Gallegos M,

Advertisement

Pain management 2017 02 07() doi 10.2217/pmt-2016-0065
Abstract
AIM
Latin-American experts in the use of opioids in patients with chronic nononcologic pain (CNOP) have updated existing recommendations to current Latin-American reality.

METHODS
Several key opinion leaders from Latin America participated in a face-to-face meeting in Guatemala (April 2015) to discuss the use of opioids in CNOP. Subgroups of experts worked on specific topics, reviewed the literature and shaped the final manuscript.

RESULTS
The expert panel developed guidelines taking into consideration the utility of both opioid and nonopioid analgesics and factors pertaining to their efficacy, safety, adherence, administration and risks for abuse/addiction.

CONCLUSION
Latin-American guidelines for the use of opioids in CNOP should improve pain relief and patients’ quality of life by increasing access to these effective agents.

Submit a Comment

Your email address will not be published. Required fields are marked *

twelve + 10 =

[ HIDE/SHOW ]